Stay updated on Phase 1 Study in Relapsed/Refractory Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Phase 1 Study in Relapsed/Refractory Multiple Myeloma Clinical Trial page.

Latest updates to the Phase 1 Study in Relapsed/Refractory Multiple Myeloma Clinical Trial page
- Check3 days agoChange DetectedThe displayed ClinicalTrials.gov site revision changes from v3.7.2 to v3.8.0, while the study record information remains unchanged.SummaryDifference0.1%

- Check10 days agoChange DetectedAn NIH banner announces a terminology transition from “Artificial Intelligence” to “Super Intelligence” across NIH content. It is unrelated to the study record.SummaryDifference0.6%

- Check17 days agoChange DetectedThe site revision indicator in the footer changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check24 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check45 days agoChange DetectedThe study's version history now shows a new revision entry v3.7.0 and removes the previous revision v3.6.6, updating the record to reflect the latest version.SummaryDifference0.1%

- Check66 days agoChange DetectedThe history entry shows a new minor page revision to v3.6.6. This indicates a metadata or cosmetic update to the record rather than any substantive changes to the trial data or status.SummaryDifference0.1%

Stay in the know with updates to Phase 1 Study in Relapsed/Refractory Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 1 Study in Relapsed/Refractory Multiple Myeloma Clinical Trial page.